US Patent 8828427 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
Patent 8828427 was granted and assigned to Celgene on September, 2014 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8828427 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
